Alfredo Berruti

2.2k total citations
12 papers, 768 citations indexed

About

Alfredo Berruti is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alfredo Berruti has authored 12 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Cancer Research and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alfredo Berruti's work include Adrenal and Paraganglionic Tumors (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Pituitary Gland Disorders and Treatments (6 papers). Alfredo Berruti is often cited by papers focused on Adrenal and Paraganglionic Tumors (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Pituitary Gland Disorders and Treatments (6 papers). Alfredo Berruti collaborates with scholars based in Italy, France and Netherlands. Alfredo Berruti's co-authors include Martin Faßnacht, Harm R. Haak, Massimo Terzolo, F. Porpiglia, G. Pentheroudakis, Eric Baudin, Hans Gelderblom, Fulvia Daffara, Luigi Dogliotti and Paola Sperone and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Alfredo Berruti

12 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfredo Berruti Italy 9 647 516 395 228 121 12 768
Shamim Ejaz United States 7 622 1.0× 389 0.8× 491 1.2× 110 0.5× 91 0.8× 9 723
Barbara Zaggia Italy 15 864 1.3× 666 1.3× 588 1.5× 229 1.0× 60 0.5× 24 967
Thomas Kerkhofs Netherlands 12 552 0.9× 406 0.8× 368 0.9× 160 0.7× 42 0.3× 20 637
Maria Candida Barisson Villares Fragoso Brazil 14 366 0.6× 200 0.4× 309 0.8× 82 0.4× 41 0.3× 48 500
G. Abiven France 3 557 0.9× 426 0.8× 358 0.9× 130 0.6× 29 0.2× 5 581
Marc D. Wooten United States 7 240 0.4× 171 0.3× 137 0.3× 94 0.4× 78 0.6× 11 455
David Taïeb France 11 252 0.4× 119 0.2× 269 0.7× 79 0.3× 69 0.6× 15 458
Felix Megerle Germany 12 397 0.6× 290 0.6× 244 0.6× 129 0.6× 40 0.3× 17 446
J M Duclos France 10 483 0.7× 292 0.6× 381 1.0× 58 0.3× 63 0.5× 16 669
Christopher P. Bambach Australia 10 408 0.6× 402 0.8× 203 0.5× 73 0.3× 41 0.3× 12 619

Countries citing papers authored by Alfredo Berruti

Since Specialization
Citations

This map shows the geographic impact of Alfredo Berruti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Berruti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Berruti more than expected).

Fields of papers citing papers by Alfredo Berruti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Berruti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Berruti. The network helps show where Alfredo Berruti may publish in the future.

Co-authorship network of co-authors of Alfredo Berruti

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Berruti. A scholar is included among the top collaborators of Alfredo Berruti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Berruti. Alfredo Berruti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ferrero, Annamaria, Paola Sperone, Arianna Ardito, et al.. (2013). Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.. PubMed. 36(3). 148–52. 13 indexed citations
2.
Berruti, Alfredo, Eric Baudin, Hans Gelderblom, et al.. (2012). Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23. vii131–vii138. 217 indexed citations
3.
Fiori, Cristian, Fulvia Daffara, Barbara Zaggia, et al.. (2012). 1105 Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results?. European Urology Supplements. 11(1). e1105–e1105a. 2 indexed citations
4.
Faßnacht, Martin, Massimo Terzolo, Bruno Allolio, et al.. (2011). Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study. 26. 2 indexed citations
5.
Berruti, Alfredo, Paola Sperone, Annamaria Ferrero, et al.. (2011). Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. European Journal of Endocrinology. 166(3). 451–458. 104 indexed citations
6.
Berruti, Alfredo, Paola Sperone, Elisa Bellini, et al.. (2011). Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma. Hormones and Cancer. 2(6). 378–384. 11 indexed citations
7.
Hermsen, I G C, Martin Faßnacht, Massimo Terzolo, et al.. (2011). Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1844–1851. 127 indexed citations
8.
Sperone, Paola, Annamaria Ferrero, Fulvia Daffara, et al.. (2010). Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. Endocrine Related Cancer. 17(2). 445–453. 110 indexed citations
9.
Sperone, Paola, Alfredo Berruti, G. Gorzegno, et al.. (2006). Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. Journal of Endocrinological Investigation. 29(6). 560–562. 8 indexed citations
10.
Saini, Andrea, Alfredo Berruti, Paola Sperone, et al.. (2006). Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. The Lancet Oncology. 7(2). 186–187. 5 indexed citations
11.
Bretti, S., Alfredo Berruti, Paola Sperone, et al.. (2003). Multimodal management of stages III–IVa malignant thymoma. Lung Cancer. 44(1). 69–77. 81 indexed citations
12.
Terzolo, Massimo, Anna Pia, Alfredo Berruti, et al.. (2000). Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer1. The Journal of Clinical Endocrinology & Metabolism. 85(6). 2234–2238. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026